aerophobin-1

Also Known As:

(5r,6s)-7,9-bis(bromanyl)-n-(2-(1h-imidazol-5-yl)ethyl)-8-methoxy-6-oxidanyl-1-oxa-2-azaspiro(4.5)deca-2,7,9-triene-3-carboxamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Banfi, Giuseppe: 1 article (02/2022)
2.	Carbone, Marianna: 1 article (02/2022)
3.	Carnovali, Marta: 1 article (02/2022)
4.	Ciavatta, Maria Letizia: 1 article (02/2022)
5.	Mariotti, Massimo: 1 article (02/2022)
6.	Mollo, Ernesto: 1 article (02/2022)
7.	Roussis, Vassilios: 1 article (02/2022)

1.	Osteoporosis 02/11/2022 - "Obtained results led to the selection of aerophobin-1 (1) as a promising candidate for applications in regenerative medicine, paving the way for the development of a novel therapeutic option in osteoporosis treatment."